These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9753056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
    Martinelli G, Testoni N, Amabile M, Bonifazi F, De Vivo A, Farabegoli P, Terragna C, Montefusco V, Ottaviani E, Saglio G, Russo D, Baccarani M, Rosti G, Tura S.
    Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
    [Abstract] [Full Text] [Related]

  • 7. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics.
    Branford S, Hughes TP, Rudzki Z.
    Br J Haematol; 1999 Dec; 107(3):587-99. PubMed ID: 10583264
    [Abstract] [Full Text] [Related]

  • 8. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
    Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC.
    Blood; 1996 Feb 15; 87(4):1549-55. PubMed ID: 8608246
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
    Song YQ, Li W, Kong LH, Wang GJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb 15; 11(1):38-40. PubMed ID: 12667287
    [Abstract] [Full Text] [Related]

  • 11. Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.
    Hochhaus A, Reiter A, Saussele S, Reichert A, Emig M, Kaeda J, Schultheis B, Berger U, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC.
    Blood; 2000 Jan 01; 95(1):62-6. PubMed ID: 10607685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study.
    Yin JL, Williams BG, Arthur CK, Ma DD.
    Br J Haematol; 1995 Mar 01; 89(3):539-45. PubMed ID: 7734352
    [Abstract] [Full Text] [Related]

  • 15. Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity.
    Kurzrock R, Estrov Z, Kantarjian H, Talpaz M.
    J Clin Oncol; 1998 Apr 01; 16(4):1526-31. PubMed ID: 9552062
    [Abstract] [Full Text] [Related]

  • 16. Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.
    Hochhaus A, Lin F, Reiter A, Skladny H, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC.
    Br J Haematol; 1995 Sep 01; 91(1):126-31. PubMed ID: 7577619
    [Abstract] [Full Text] [Related]

  • 17. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.
    Melo JV, Hochhaus A, Yan XH, Goldman JM.
    Br J Haematol; 1996 Mar 01; 92(3):684-6. PubMed ID: 8616036
    [Abstract] [Full Text] [Related]

  • 18. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
    Müller MC, Gattermann N, Lahaye T, Deininger MW, Berndt A, Fruehauf S, Neubauer A, Fischer T, Hossfeld DK, Schneller F, Krause SW, Nerl C, Sayer HG, Ottmann OG, Waller C, Aulitzky W, le Coutre P, Freund M, Merx K, Paschka P, König H, Kreil S, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Dec 01; 17(12):2392-400. PubMed ID: 14523462
    [Abstract] [Full Text] [Related]

  • 19. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E, Krahl R, Thalmeier K, Helbig W.
    Exp Hematol; 1995 Dec 01; 23(14):1649-54. PubMed ID: 8542960
    [Abstract] [Full Text] [Related]

  • 20. Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation.
    Chomel JC, Brizard F, Veinstein A, Rivet J, Sadoun A, Kitzis A, Guilhot F, Brizard A.
    Blood; 2000 Jan 15; 95(2):404-8. PubMed ID: 10627442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.